Case Study: Rhegmatogenous Retinal Detachment

Posted on Feb 27, 2015 by



A 60 year-old male visited the Retina Institute of Hawaii complaining of poor central vision in the right eye. He began to notice vision loss inferiorly one week prior, which progressed to central vision loss two days prior to exam. The patient was CF with eccentric viewing.




Upon a dilated fundus examination, there was a macula-off superior Rhegmatogenous Retinal Detachment with a superotemporal horse-shoe tear. optomap® plus images were captured to document the retinal detachment and horseshoe tear and assist in explaining the treatment plan to the patient. A pneumatic retinopexy was immediately performed which reattached the macula.


The patient laid in the office in a face-down position for 30 minutes and was instructed to maintain the face-down position overnight. On the second day, his vision was 20/400 and the optomap revealed that the macula was reattached, and much of the subretinal fluid shifted inferiorly. It was likely he alternated between the face-down and head-up position. Laser retinopexy was performed to seal the horseshoe tear found in the superior temporal quadrant (one day after pneumatic). The patient was then asked to maintain head tilted to left, so that the pneumatic retinopexy would continue to …


Customer Spotlight: Eberle Eyecare Patients Appreciate optomap® Technology

Posted on Feb 26, 2015 by

Optos really appreciates the positive feedback we receive from our clients. Our customers are successful using our ultra-widefield retinal imaging technology and we love sharing their successes.  This customer spotlight will focus on Eberle Eyecare, a private practice in Anchorage, Alaska.


When Dr. Eberle attended the Pacific University College of Optometry, she had used optomap technology and looked forward to offering it to her patients when she opened her practice in 2010. Later, when Dr. Eberle attended the Vision Source Exchange meeting in 2013, she used that opportunity to purchase a Daytona for the benefit of her patients.


Since we had added to the modalities since she had last used optomap, Dr. Eberle took advantage of her membership with Vision Source and traveled to Scotland to learn all the nuances of using Daytona’s autofluorescence (AF) capabilities. Dr. Eberle found the training valuable and remarked, “With AF, I have the ability to isolate the cell where changes start in the disease processes,” Dr. Eberle says. “When we can pick it up earlier, the outcome is much better for the patients.”


Having purchased the Daytona for image clarity, clinical decision-making and as an aid in patient education, Dr. Eberle said she noticed the …


optomap® Helps Guide Laser Treatment for Retinal Toxicity Issue

Posted on Feb 25, 2015 by

A young woman with a history of depression, drug & alcohol abuse was seen in a Houston clinic after injecting isopropyl alcohol into her left eye. According to the patient, her eye was bothering her and she believed the rubbing alcohol would help. She went to the clinic due to a loss of vision in the eye she injected.


Visual acuity in 20/20 right eye and hand movement at 2 feet in the left eye. Intraocular pressure was 13/12 by applanation. A dilated retinal exam was performed with findings of retinal infarct, vascular pruning and a few intra-retinal hemorrhages, macular edema, rare vitreous cell and possible operculated hole at 3:00. An optomap was taken and confirmed an operculated hole and air bubble with a small hemorrhage superiorly, near the hole where patient performed the self-injection. The imaged confirmed the diagnosis of retinal toxicity, vascular ischemia, hemi-retinal artery occlusion, macular edema and a retinal hole.


The risks, benefits and alternatives of treatment discussed with patient and father. The father consented to laser treatment and a grid laser was performed. The patient was admitted to hospital for a psychiatric evaluation following the laser treatment. Four days post laser …


Find Optos at the BC Doctors of Optometry 2015 Annual Conference & OPTOFAIR

Posted on Feb 24, 2015 by

It is almost time for the BC Doctors of Optometry 2015 Annual Conference and OPTOFAIR. Being held at the Westin Bayshore Hotel from 28 February through 2 March 2015.  The event will feature education and networking opportunities for doctors of optometry, optometric assistants, and opticians. Optos will be in attendance with our ultra-widefield (UWF™) retinal imaging technology.

The BC Doctors of Optometry 2015 Annual Conference includes a program for doctors of optometry which provides 28 courses and up to 36 hours of CE credits upon completion. Additionally, 28 hours of COPE credits is included. For optometric assistants and opticians, there are 19 courses and up to 28 hours of CE credits.



Optos would like to encourage you to visit with us during the OPTOFAIR to learn more about our UWF retinal imaging technology and how it can help your practice thrive. Our UWF technology produces a high resolution 200 degree image of the retina in a single capture, and improves patient comfort since dilation is not necessarily required.


The ability to see this far into the periphery with our optomap® technology provides the opportunity to detect potential problems much earlier than exams with traditional equipment can. You …


Optos Featured at the 3rd Annual Canadian Retina Society Meeting

Posted on Feb 23, 2015 by

The third annual Canadian Retina Society Meeting is taking place from 26 February  through 1 March 2015 at the beautiful mountain resort of Whistler, British Columbia. The Canadian Retina Society and the Canadian Ophthalmology Society have teamed up to create a premiere learning experience for Canadian retina specialists, and Optos is proud to be featured at the event.




Optos is proud to be part of this exciting learning opportunity. Our ultra-widefield retinal imaging technology has been clinically proven to enable earlier diagnosis and treatment of retinal diseases. Because optomap® delivers a 200 degree view of the retina in a single scan, the high resolution images enable pathologies in the periphery to be documented and analyzed which can provide better treatment options and better patient outcomes. Be sure to stop by to find out what is new with Optos and optomap.